A Predictive Model of the Progression to Alzheimer's Disease in Patients with Mild Cognitive Impairment Based on the MRI Enlarged Perivascular Spaces

被引:0
作者
Chen, Jun [1 ]
Yang, Jingwen [1 ]
Shen, Dayong [1 ]
Wang, Xi [1 ]
Lin, Zihao [1 ]
Chen, Hao [1 ]
Cui, Guiyun [1 ]
Zhang, Zuohui [1 ,2 ]
机构
[1] Xuzhou Med Univ, Affiliated Hosp, Dept Neurol, Xuzhou 221006, Peoples R China
[2] Xuzhou Med Univ, Affiliated Hosp, Dept Neurol, Xuzhou, Jiangsu 22106, Peoples R China
基金
加拿大健康研究院;
关键词
Alzheimer's disease; mild cognitive impairment; nomogram; perivascular space; SMALL-VESSEL DISEASE; BIOMARKERS; RISK; MCI;
D O I
10.3233/JAD-240523
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Mild cognitive impairment (MCI) is a heterogeneous condition that can precede various forms of dementia, including Alzheimer's disease (AD). Identifying MCI subjects who are at high risk of progressing to AD is of major clinical relevance. Enlarged perivascular spaces (EPVS) on MRI are linked to cognitive decline, but their predictive value for MCI to AD progression is unclear. Objective: This study aims to assess the predictive value of EPVS for MCI to AD progression and develop a predictive model combining EPVS grading with clinical and laboratory data to estimate conversion risk. Methods: We analyzed 358 patients with MCI from the ADNI database, consisting of 177 MCI-AD converters and 181 non-converters. The data collected included demographic information, imaging data (including perivascular spaces grade), clinical assessments, and laboratory test results. Variable selection was conducted using the Least Absolute Shrinkage and Selection Operator (LASSO) method, followed by logistic regression to develop predictive model. Results: In the univariate logistic regression analysis, both moderate (OR = 5.54, 95% CI [3.04-10.18]) and severe (OR =25.04, 95% CI [10.07-62.23]) enlargements of the centrum semiovale perivascular space (CSO-PVS) were found to be strong predictors of disease progression. LASSO analyses yielded 12 variables, refined to six in the final model: APOE4 genotype, ADAS11 score, CSO-PVS grade, and volumes of entorhinal, fusiform, and midtemporal regions, with an AUC of 0.956 in the training and 0.912 in the validation cohort. Conclusions: Our predictive model, emphasizing EPVS assessment, provides clinicians with a practical tool for early detection and management of AD risk in MCI patients.
引用
收藏
页码:159 / 173
页数:15
相关论文
共 50 条
  • [31] Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment
    Ardekani, Babak A.
    Bermudez, Elaine
    Mubeen, Asim M.
    Bachman, Alvin H.
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 55 (01) : 269 - 281
  • [32] Association of Enlarged Perivascular Spaces With Amyloid Burden and Cognitive Decline in Alzheimer Disease Continuum
    Jeong, Seong Ho
    Cha, Jungho
    Park, Mincheol
    Jung, Jin Ho
    Ye, Byoung Seok
    Sohn, Young H.
    Chung, Seok Jong
    Lee, Phil Hyu
    NEUROLOGY, 2022, 99 (16) : E1791 - E1802
  • [33] Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects
    Dietlin, Simon
    Soto, Maria
    Kiyasova, Vera
    Pueyo, Maria
    de Mauleon, Adelaide
    Delrieu, Julien
    Ousset, Pierre Jean
    Vellas, Bruno
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 70 (01) : 25 - 34
  • [34] Impact of vascular diseases on the progression of mild cognitive impairment to Alzheimer's disease
    Nesteruk, Marta
    Nesteruk, Tomasz
    Styczynska, Maria
    Barcikowska, Maria
    AKTUALNOSCI NEUROLOGICZNE, 2015, 15 (01): : 18 - 21
  • [35] Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease
    Marizzoni, Moira
    Ferrari, Clarissa
    Macis, Ambra
    Jovicich, Jorge
    Albani, Diego
    Babiloni, Claudio
    Cavaliere, Libera
    Didic, Mira
    Forloni, Gianluigi
    Galluzzi, Samantha
    Hoffmann, Karl-Titus
    Molinuevo, Jose Luis
    Nobili, Flavin
    Parnetti, Lucilla
    Payoux, Pierre
    Pizzini, Francesca
    Rossini, Paolo Maria
    Salvatore, Marco
    Schoenknecht, Peter
    Soricelli, Andrea
    Del Percio, Claudio
    Hensch, Tilman
    Hegerl, Ulrich
    Tsolaki, Magda
    Visser, Pieter Jelle
    Wiltfang, Jens
    Richardson, Jill C.
    Bordet, Regis
    Blin, Olivier
    Frisoni, Giovanni B.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 69 (01) : 49 - 58
  • [36] Risk Classification in Mild Cognitive Impairment Patients for Developing Alzheimer's Disease
    Zhou, Bin
    Nakatani, Eiji
    Teramukai, Satoshi
    Nagai, Yoji
    Fukushima, Masanori
    JOURNAL OF ALZHEIMERS DISEASE, 2012, 30 (02) : 367 - 375
  • [37] Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls
    Westman, Eric
    Simmons, Andrew
    Zhang, Yi
    Muehlboeck, J-Sebastian
    Tunnard, Catherine
    Liu, Yawu
    Collins, Louis
    Evans, Alan
    Mecocci, Patrizia
    Vellas, Bruno
    Tsolaki, Magda
    Kloszewska, Iwona
    Soininen, Hilkka
    Lovestone, Simon
    Spenger, Christian
    Wahlund, Lars-Olof
    NEUROIMAGE, 2011, 54 (02) : 1178 - 1187
  • [38] Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease
    Lim, Y. Y.
    Kong, J.
    Maruff, P.
    Jaeger, J.
    Huang, E.
    Ratti, E.
    JPAD-JOURNAL OF PREVENTION OF ALZHEIMERS DISEASE, 2022, 9 (01): : 178 - 183
  • [39] Markers of amyloid-β deposition and burden of enlarged perivascular spaces in patients with cognitive impairment and small vessel disease
    Costa, Ana Sofia
    Exalto, Lieza G.
    van der Flier, Wiesje M.
    Teunissen, Charlotte E.
    Barkhof, Frederik
    Kuijf, Hugo J.
    Biessels, Geert Jan
    TRACE-VCI Study Grp
    JOURNAL OF ALZHEIMERS DISEASE, 2024, 102 (04) : 981 - 986
  • [40] Olfactory memory in mild cognitive impairment and Alzheimer's disease
    Audronyte, Egle
    Sutnikiene, Vaiva
    Pakulaite-Kazliene, Gyte
    Kaubrys, Gintaras
    FRONTIERS IN NEUROLOGY, 2023, 14